development pipeline

Pipeline – Drugs for rare diseases

NAME	ORIGINATOR	INDICATION	DEVELOPMENT STATUS
Carbaglu®	Orphan Europe (Recordati)	Organic acidemias	Approved in the EU, Phase III in U.S.A.
Cystadrops®	Orphan Europe (Recordati)	Ocular cystinosis	Phase II